Skip to content
Menu
Technology
3D-EXpress
Applications
Oncology Applications
Biomarker Discovery
Oncolytic Virus
Cell Therapies
Antibody Based Therapeutics
Chemotherapies / Targeted Therapies
HOLISTIC DRUG DEVELOPMENT
Whatever your therapeutic application needs, we have the right model for you
Contact Us
Services
Overview
Tumor Cell Killing
Multiplex Cytokine Analysis
Gene Expression & Proteomics Analysis
High Content Imaging
Flow Cytometry
Multiplex IHC
Resources
Presentations & Posters
Publications
Events
Webinars
Blog
About
About Nilogen
Our Team
Careers
News
Contact Us
Technology
3D-EXpress
Applications
Biomarker Discovery
Cell Therapies
Oncolytic Virus
Antibody Based Therapeutics
Chemotherapies / Targeted Therapies
Services
Tumor Cell Killing
Multiplex Cytokine Analysis
Gene Expression & Proteomics Analysis
High Content Imaging
Flow Cytometry
Multiplex IHC Service
Resources
Presentations & Posters
Publications
Events
Webinars
Blog
About
About Nilogen
Our Team
Careers
News
Contact Us
View All Blog
A Patient-driven Ex Vivo 3D Tumor Organoid Model to Assess Efficacy of Tumor Infiltrating T-cell Adoptive Cell Therapy
Related Blog
Searching for the proverbial needle in a haystack. Biomarkers unleashed.
Why intact TME is essential for oncology drug development
Why Tumoroids are not tumor organoids
